Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours

Robin L. Jones*, Mark J. Ratain, Peter J. O'Dwyer, Lillian L. Siu, Jacek Jassem, Jacques Medioni, Maja DeJonge, Charles Rudin, Michael Sawyer, David Khayat, Ahmad Awada, Judith M. P. G. M. de Vos-Geelen, T. R. Jeffry Evans, Jennifer Obel, Bruce Brockstein, Jacques DeGreve, Jean-Francois Baurain, Robert Maki, David D'Adamo, Mark DicksonSamir Undevia, David Geary, Linda Janisch, Philippe L. Bedard, Albiruni R. Abdul Razak, Rebecca Kristeleit, Joanna Vitfell-Rasmussen, Ian Walters, Stan B. Kaye, Gary Schwartz

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)132-139
Number of pages8
JournalEuropean Journal of Cancer
Volume120
DOIs
Publication statusPublished - Oct 2019

Keywords

  • Brivanib
  • Solid tumours
  • Randomised discontinuation trial
  • FGF2 status
  • Sarcomas
  • Ovarian cancer
  • GROWTH-FACTOR RECEPTOR-2
  • SOFT-TISSUE SARCOMA
  • INHIBITOR
  • PAZOPANIB

Cite this

Jones, R. L., Ratain, M. J., O'Dwyer, P. J., Siu, L. L., Jassem, J., Medioni, J., ... Schwartz, G. (2019). Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours. European Journal of Cancer, 120, 132-139. https://doi.org/10.1016/j.ejca.2019.07.024
Jones, Robin L. ; Ratain, Mark J. ; O'Dwyer, Peter J. ; Siu, Lillian L. ; Jassem, Jacek ; Medioni, Jacques ; DeJonge, Maja ; Rudin, Charles ; Sawyer, Michael ; Khayat, David ; Awada, Ahmad ; de Vos-Geelen, Judith M. P. G. M. ; Evans, T. R. Jeffry ; Obel, Jennifer ; Brockstein, Bruce ; DeGreve, Jacques ; Baurain, Jean-Francois ; Maki, Robert ; D'Adamo, David ; Dickson, Mark ; Undevia, Samir ; Geary, David ; Janisch, Linda ; Bedard, Philippe L. ; Razak, Albiruni R. Abdul ; Kristeleit, Rebecca ; Vitfell-Rasmussen, Joanna ; Walters, Ian ; Kaye, Stan B. ; Schwartz, Gary. / Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours. In: European Journal of Cancer. 2019 ; Vol. 120. pp. 132-139.
@article{e3fe8ecd04374adc941ecb7a4cd257d6,
title = "Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours",
keywords = "Brivanib, Solid tumours, Randomised discontinuation trial, FGF2 status, Sarcomas, Ovarian cancer, GROWTH-FACTOR RECEPTOR-2, SOFT-TISSUE SARCOMA, INHIBITOR, PAZOPANIB",
author = "Jones, {Robin L.} and Ratain, {Mark J.} and O'Dwyer, {Peter J.} and Siu, {Lillian L.} and Jacek Jassem and Jacques Medioni and Maja DeJonge and Charles Rudin and Michael Sawyer and David Khayat and Ahmad Awada and {de Vos-Geelen}, {Judith M. P. G. M.} and Evans, {T. R. Jeffry} and Jennifer Obel and Bruce Brockstein and Jacques DeGreve and Jean-Francois Baurain and Robert Maki and David D'Adamo and Mark Dickson and Samir Undevia and David Geary and Linda Janisch and Bedard, {Philippe L.} and Razak, {Albiruni R. Abdul} and Rebecca Kristeleit and Joanna Vitfell-Rasmussen and Ian Walters and Kaye, {Stan B.} and Gary Schwartz",
year = "2019",
month = "10",
doi = "10.1016/j.ejca.2019.07.024",
language = "English",
volume = "120",
pages = "132--139",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "ELSEVIER SCI LTD",

}

Jones, RL, Ratain, MJ, O'Dwyer, PJ, Siu, LL, Jassem, J, Medioni, J, DeJonge, M, Rudin, C, Sawyer, M, Khayat, D, Awada, A, de Vos-Geelen, JMPGM, Evans, TRJ, Obel, J, Brockstein, B, DeGreve, J, Baurain, J-F, Maki, R, D'Adamo, D, Dickson, M, Undevia, S, Geary, D, Janisch, L, Bedard, PL, Razak, ARA, Kristeleit, R, Vitfell-Rasmussen, J, Walters, I, Kaye, SB & Schwartz, G 2019, 'Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours', European Journal of Cancer, vol. 120, pp. 132-139. https://doi.org/10.1016/j.ejca.2019.07.024

Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours. / Jones, Robin L.; Ratain, Mark J.; O'Dwyer, Peter J.; Siu, Lillian L.; Jassem, Jacek; Medioni, Jacques; DeJonge, Maja; Rudin, Charles; Sawyer, Michael; Khayat, David; Awada, Ahmad; de Vos-Geelen, Judith M. P. G. M.; Evans, T. R. Jeffry; Obel, Jennifer; Brockstein, Bruce; DeGreve, Jacques; Baurain, Jean-Francois; Maki, Robert; D'Adamo, David; Dickson, Mark; Undevia, Samir; Geary, David; Janisch, Linda; Bedard, Philippe L.; Razak, Albiruni R. Abdul; Kristeleit, Rebecca; Vitfell-Rasmussen, Joanna; Walters, Ian; Kaye, Stan B.; Schwartz, Gary.

In: European Journal of Cancer, Vol. 120, 10.2019, p. 132-139.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours

AU - Jones, Robin L.

AU - Ratain, Mark J.

AU - O'Dwyer, Peter J.

AU - Siu, Lillian L.

AU - Jassem, Jacek

AU - Medioni, Jacques

AU - DeJonge, Maja

AU - Rudin, Charles

AU - Sawyer, Michael

AU - Khayat, David

AU - Awada, Ahmad

AU - de Vos-Geelen, Judith M. P. G. M.

AU - Evans, T. R. Jeffry

AU - Obel, Jennifer

AU - Brockstein, Bruce

AU - DeGreve, Jacques

AU - Baurain, Jean-Francois

AU - Maki, Robert

AU - D'Adamo, David

AU - Dickson, Mark

AU - Undevia, Samir

AU - Geary, David

AU - Janisch, Linda

AU - Bedard, Philippe L.

AU - Razak, Albiruni R. Abdul

AU - Kristeleit, Rebecca

AU - Vitfell-Rasmussen, Joanna

AU - Walters, Ian

AU - Kaye, Stan B.

AU - Schwartz, Gary

PY - 2019/10

Y1 - 2019/10

KW - Brivanib

KW - Solid tumours

KW - Randomised discontinuation trial

KW - FGF2 status

KW - Sarcomas

KW - Ovarian cancer

KW - GROWTH-FACTOR RECEPTOR-2

KW - SOFT-TISSUE SARCOMA

KW - INHIBITOR

KW - PAZOPANIB

U2 - 10.1016/j.ejca.2019.07.024

DO - 10.1016/j.ejca.2019.07.024

M3 - Article

VL - 120

SP - 132

EP - 139

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

ER -